Cargando…

Friend leukemia virus integration 1 is a predictor of poor prognosis of breast cancer and promotes metastasis and cancer stem cell properties of breast cancer cells

Breast cancer is the most common cancer in women worldwide; despite the developments in diagnosis and therapy, recurrence and metastasis remain the main causes of death among patients with breast cancer. This study aimed to identify a promising biomarker for this disease. The study clarified (1) the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Xu, Yu, Yu, Li, Lingyu, Chen, Naifei, Song, Wei, He, Hua, Dong, Jie, Liu, Xiangliang, Cui, Jiuwei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Clinical Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6089157/ https://www.ncbi.nlm.nih.gov/pubmed/29869379 http://dx.doi.org/10.1002/cam4.1589

Ejemplares similares

Friend leukemia virus integration 1 activates the Rho GTPase pathway and is associated with metastasis in breast cancer
por: Song, Wei, et al.
Publicado: (2015)

PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer
por: Zhang, Min, et al.
Publicado: (2020)

Efficacy of second-line treatments for patients with advanced human epidermal growth factor receptor 2 positive breast cancer after trastuzumab-based treatment: a systematic review and bayesian network analysis
por: Chen, Fei, et al.
Publicado: (2021)

Single Nucleotide Polymorphisms in HOTAIR Are Related to Breast Cancer Risk and Prognosis in the Northeastern Chinese Population
por: Lv, Zheng, et al.
Publicado: (2021)

Neoadjuvant and Adjuvant Immunotherapy: Opening New Horizons for Patients With Early-Stage Non-small Cell Lung Cancer
por: Bai, Rilan, et al.
Publicado: (2020)

Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy
por: Chen, Fei, et al.
Publicado: (2022)

Upregulation of miR‐374a promotes tumor metastasis and progression by downregulating LACTB and predicts unfavorable prognosis in breast cancer
por: Zhang, Jun, et al.
Publicado: (2018)

Favorable Immune Microenvironment in Patients with EGFR and MAPK Co-Mutations
por: Yang, Wang, et al.
Publicado: (2020)

Osteoprotegerin expression in triple-negative breast cancer cells promotes metastasis
por: Weichhaus, Michael, et al.
Publicado: (2014)

Three inflammation‐related genes could predict risk in prognosis and metastasis of patients with breast cancer
por: Zhao, Shuangtao, et al.
Publicado: (2019)

Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway
por: Li, Lingyu, et al.
Publicado: (2017)

miR‐18a activates Wnt pathway in ER‐positive breast cancer and is associated with poor prognosis
por: Nair, Madhumathy G, et al.
Publicado: (2020)

Soluble Neuropilin-1 is an independent marker of poor prognosis in early breast cancer
por: Rachner, Tilman D., et al.
Publicado: (2021)

Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery
por: Garvin, Stina, et al.
Publicado: (2018)

Efficacy and Safety of Epidermal Growth Factor Receptor (EGFR) Inhibitors Plus Antiangiogenic Agents as First-Line Treatments for Patients With Advanced EGFR-Mutated Non-small Cell Lung Cancer: A Meta-Analysis
por: Chen, Fei, et al.
Publicado: (2020)

The role of EMT-related lncRNA in the process of triple-negative breast cancer metastasis
por: Zhang, Haomeng, et al.
Publicado: (2021)

Mechanisms of Cancer Resistance to Immunotherapy
por: Bai, Rilan, et al.
Publicado: (2020)

A novel FLI1 exonic circular RNA promotes metastasis in breast cancer by coordinately regulating TET1 and DNMT1
por: Chen, Naifei, et al.
Publicado: (2018)

Elevated serum HER‐2 predicts poor prognosis in breast cancer and is correlated to ADAM10 expression
por: Zheng, Hui, et al.
Publicado: (2019)

Gamma-delta (γδ) T cells: friend or foe in cancer development?
por: Zhao, Yijing, et al.
Publicado: (2018)

Targeted therapy combined with immunotherapy in patients with breast infiltrating ductal carcinoma with axillary lymph node metastasis of metaplastic SCC
por: Bai, Rilan, et al.
Publicado: (2022)

Referral process to further evaluate poor sleep in breast cancer survivors
por: Otte, Julie L., et al.
Publicado: (2022)

Relationship between thymidine kinase 1 before radiotherapy and prognosis in breast cancer patients with diabetes
por: Wang, Zhiwu, et al.
Publicado: (2020)

Association of human breast cancer CD44(-)/CD24(-) cells with delayed distant metastasis
por: Qiao, Xinbo, et al.
Publicado: (2021)

Up-regulation of CXCL8 expression is associated with a poor prognosis and enhances tumor cell malignant behaviors in liver cancer
por: Yang, Song, et al.
Publicado: (2020)

Lamin B2 promotes the progression of triple negative breast cancer via mediating cell proliferation and apoptosis
por: Zhao, Cui-Cui, et al.
Publicado: (2021)

Musashi2 as a novel predictive biomarker for liver metastasis and poor prognosis in colorectal cancer
por: Zong, Zhen, et al.
Publicado: (2016)

Novel Frontiers of Treatment for Advanced Gastric or Gastroesophageal Junction Cancer (GC/GEJC): Will Immunotherapy Be a Future Direction?
por: Bai, Rilan, et al.
Publicado: (2020)

Correction to: Gamma-delta (γδ) T cells: friend or foe in cancer development?
por: Zhao, Yijing, et al.
Publicado: (2018)

miR-219-5p targets TBXT and inhibits breast cancer cell EMT and cell migration and invasion
por: Ye, Qin, et al.
Publicado: (2021)

Ultrasonic irradiation and SonoVue microbubbles-mediated RNA interference targeting PRR11 inhibits breast cancer cells proliferation and metastasis, but promotes apoptosis
por: Luo, Hui, et al.
Publicado: (2020)

OGFOD1 is required for breast cancer cell proliferation and is associated with poor prognosis in breast cancer
por: Kim, Jae-Hwan, et al.
Publicado: (2015)

Cystic brain metastasis is associated with poor prognosis in patients with advanced breast cancer
por: Sun, Bing, et al.
Publicado: (2016)

Overexpression of CENPF correlates with poor prognosis and tumor bone metastasis in breast cancer
por: Sun, Jingbo, et al.
Publicado: (2019)

Cytoplasmic LXR expression is an independent marker of poor prognosis for patients with early stage primary breast cancer
por: Shao, Wanting, et al.
Publicado: (2021)

Amplification of the CD24 Gene Is an Independent Predictor for Poor Prognosis of Breast Cancer
por: Zhang, Peng, et al.
Publicado: (2019)

Loss of cytoplasmic survivin expression is an independent predictor of poor prognosis in radically operated prostate cancer patients
por: Büscheck, Franziska, et al.
Publicado: (2020)

NRF3 suppresses breast cancer cell metastasis and cell proliferation and is a favorable predictor of survival in breast cancer
por: Sun, Jianguo, et al.
Publicado: (2019)

Association between breast cancer and thyroid cancer: A study based on 13 978 patients with breast cancer
por: Huang, Nai‐si, et al.
Publicado: (2018)

A Portal Vein Injection Model to Study Liver Metastasis of Breast Cancer
por: Goddard, Erica T., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ue30dldmac1pitpv15o1698e61